A prospective clinical utility study demonstrates that physicians use the 40-gene expression profile (40-GEP) to guide clinical management decisions for Medicare-eligible patients with cutaneous squamous cell carcinoma (cSCC)
SKIN The Journal of Cutaneous Medicine（2022）
关键词
cutaneous squamous cell carcinoma,clinical management decisions,medicare-eligible
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要